Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028
As mentioned in Triton’s research report, the Asia-Pacific nasal spray
market is anticipated to display growth in its revenues at 9.24% of the
compound annual growth rate during the evaluated years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market include:
• India
• China
• Japan
• Australia & New
Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
In the region, chronic rhinosinusitis affects a large amount of the
population. In addition to this, asthma has become highly prevalent, with
chronic obstructive pulmonary diseases becoming a leading cause of death across
the region. This surge in respiratory diseases is mainly owing to the increase
in air pollution levels. Additionally, the rising geriatric population has
increased the risk of respiratory diseases across Japan, Thailand, and South
Korea. These are some of the key factors fueling the growth of the nasal spray
market across the region.
In China, for instance, Allergic Rhinitis has become a major health
problem leading to various disorders. As per estimates, chronic rhinosinusitis
affects around 8% of adults. Other than this, chronic obstructive pulmonary
disease is highly prevalent in the country, with smoking and biomass fuels
being the major cause of this disease. This rise in respiratory diseases
enhances the demand for nasal sprays across the country. Hence, these factors
are expected to widen the scope of the nasal spray market within China over the
upcoming years.
Bharat Biotech is a biotechnology company specializing in
product-oriented research and development of vaccines and bio-therapeutics. It
is engaged in manufacturing vaccines for various diseases, such as typhoid,
rotavirus, polio, rabies, and others. Its product line includes BBV154, which
is an intranasal vaccine for COVID-19. Bharat Biotech serves various clients
and is headquartered in Hyderabad, India.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
NASAL SPRAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON NASAL SPRAY MARKET
2.2. KEY
INSIGHTS
2.2.1. ALLERGY
TREATMENTS WITH NASAL SPRAYS
2.2.2. UTILIZING
NASAL SPRAY FOR DIABETES
2.2.3. ENDOMETRIOSIS
TREATMENT WITH NASAL SPRAYS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. EMERGING
INTRANASAL VACCINES FOR COVID-19
2.7.2. INCREASING
ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION
2.7.3. GROWING
USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES
2.8. MARKET
CHALLENGES
2.8.1. COMPLICATIONS
DUE TO EXCESS USE OF NASAL SPRAYS
2.9. MARKET
OPPORTUNITIES
2.9.1. APPLICATION
OF NASAL SPRAYS IN TREATING DEPRESSION
2.9.2. USING
INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
2.9.3. EMPLOYING
NASAL SPRAY AS A VACCINE
3. ASIA-PACIFIC
NASAL SPRAY MARKET OUTLOOK - BY TYPE
3.1. DECONGESTION
NASAL SPRAY
3.2. STEROID
NASAL SPRAY
3.3. SALTWATER
SOLUTION/SALINE NASAL SPRAY
4. ASIA-PACIFIC
NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION
4.1. OVER-THE-COUNTER
4.2. PRESCRIBED
5. ASIA-PACIFIC
NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC
5.1. ANTIHISTAMINE
5.2. NASAL
STEROIDS
5.3. ANTICHOLINERGIC
5.4. MAST
CELL INHIBITOR
6. ASIA-PACIFIC
NASAL SPRAY MARKET OUTLOOK - BY APPLICATION
6.1. NASAL
CONGESTION
6.2. ALLERGIC
AND NON-ALLERGIC RHINITIS
6.3. VACCINATION
6.4. CNS
DISORDERS
6.5. OTHER
APPLICATIONS
7. ASIA-PACIFIC
NASAL SPRAY MARKET OUTLOOK - BY END-USER
7.1. HOME
CARE SETTING
7.2. ASC/CLINICS
7.3. PHARMACY
7.4. HOSPITAL
7.5. OTHER END-USERS
8. ASIA-PACIFIC
NASAL SPRAY MARKET – REGIONAL OUTLOOK
8.1. CHINA
8.2. JAPAN
8.3. INDIA
8.4. SOUTH
KOREA
8.5. ASEAN
COUNTRIES
8.6. AUSTRALIA
& NEW ZEALAND
8.7. REST
OF ASIA-PACIFIC
9. COMPETITIVE
LANDSCAPE
9.1. AKORN
9.2. ALLERGAN
9.3. APOTEX
INC
9.4. BHARAT
BIOTECH
9.5. CATALENT
INC
9.6. CIPLA
LIMITED
9.7. GLAXOSMITHKLINE
9.8. JOHNSON
AND JOHNSON
9.9. NOVARTIS
INTERNATIONAL AG
9.10. PFIZER
INC
9.11. PROCTOR
AND GAMBLE CO
9.12. SANOTIZE
RESEARCH AND DEVELOPMENT
9.13. SUN
PHARMACEUTICALS INDUSTRIES LTD
9.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
9.15. VIATRIS
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: ASIA-PACIFIC NASAL
SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC NASAL
SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC NASAL
SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC NASAL
SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC NASAL
SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC NASAL
SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: ASIA-PACIFIC NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE
3: ASIA-PACIFIC NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN
$ MILLION)
FIGURE
4: ASIA-PACIFIC NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $
MILLION)
FIGURE
5: ASIA-PACIFIC NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY,
2021-2028 (IN $ MILLION)
FIGURE
6: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)
FIGURE
7: ASIA-PACIFIC NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $
MILLION)
FIGURE
8: ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE
9: ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)
FIGURE
10: ASIA-PACIFIC NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)
FIGURE
11: ASIA-PACIFIC NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $
MILLION)
FIGURE
12: ASIA-PACIFIC NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $
MILLION)
FIGURE
13: ASIA-PACIFIC NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $
MILLION)
FIGURE
14: ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
15: ASIA-PACIFIC NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $
MILLION)
FIGURE
16: ASIA-PACIFIC NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS,
2021-2028 (IN $ MILLION)
FIGURE
17: ASIA-PACIFIC NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE
18: ASIA-PACIFIC NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE
19: ASIA-PACIFIC NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $
MILLION)
FIGURE
20: ASIA-PACIFIC NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE
21: ASIA-PACIFIC NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $
MILLION)
FIGURE
22: ASIA-PACIFIC NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
23: ASIA-PACIFIC NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE
24: ASIA-PACIFIC NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE
25: ASIA-PACIFIC NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $
MILLION)
FIGURE
26: ASIA-PACIFIC NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE
27: CHINA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: JAPAN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
29: INDIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
30: SOUTH KOREA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
31: ASEAN COUNTRIES NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
32: AUSTRALIA & NEW ZEALAND NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
33: REST OF ASIA-PACIFIC NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)